-+ 0.00%
-+ 0.00%
-+ 0.00%

MAPLIGHT THERAPEUTICS - Q3 NET LOSS $51.60 MLN, Q3 NET LOSS PER SHARE $0.97

Reuters·11/16/2026 12:18:21